{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:30:10Z","timestamp":1770237010128,"version":"3.49.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0234260","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T17:27:25Z","timestamp":1591896445000},"page":"e0234260","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["The role of diabetes in cardiomyopathies of different etiologies\u2014Characteristics and 1-year follow-up results of the EVITA-HF registry"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7086-0469","authenticated-orcid":true,"given":"Christine","family":"Meindl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hochadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Frankenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Bruder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Pauschinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Hambrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"von Scheidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otmar","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars S.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Senges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Uns\u00f6ld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"issue":"9922","key":"pone.0234260.ref001","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"S.E. Kahn","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"pone.0234260.ref002","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"S. Rubler","year":"1972","journal-title":"Am J Cardiol"},{"issue":"1","key":"pone.0234260.ref003","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euje.2005.03.009","article-title":"The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients","volume":"7","author":"R. Valle","year":"2006","journal-title":"Eur J Echocardiogr"},{"issue":"10","key":"pone.0234260.ref004","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.2337\/db13-0683","article-title":"Diabetes and the heart: is there objective evidence of a human diabetic cardiomyopathy?","volume":"62","author":"S.E. Litwin","year":"2013","journal-title":"Diabetes"},{"issue":"8","key":"pone.0234260.ref005","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jacc.2006.07.033","article-title":"Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography","volume":"48","author":"M. Galderisi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"pone.0234260.ref006","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1463-1326.2006.00607.x","article-title":"Diagnostic utility of brain-natriuretic peptide for left ventricular diastolic dysfunction in asymptomatic type 2 diabetic patients","volume":"9","author":"M. Shimabukuro","year":"2007","journal-title":"Diabetes Obes Metab"},{"issue":"9474","key":"pone.0234260.ref007","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(05)66621-4","article-title":"Heart failure","volume":"365","author":"J.J. McMurray","year":"2005","journal-title":"Lancet"},{"issue":"11","key":"pone.0234260.ref008","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","article-title":"Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling","volume":"131","author":"R.A. Frieler","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"pone.0234260.ref009","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"D.L. Mann","year":"2015","journal-title":"Circ Res"},{"issue":"1","key":"pone.0234260.ref010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis","volume":"119","author":"S.D. Prabhu","year":"2016","journal-title":"Circ Res"},{"issue":"25","key":"pone.0234260.ref011","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"S. Boudina","year":"2007","journal-title":"Circulation"},{"issue":"19","key":"pone.0234260.ref012","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMc1303158","article-title":"Autophagy in human health and disease","volume":"368","author":"A.M. Choi","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0234260.ref013","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","article-title":"Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension","volume":"28","author":"M. Testa","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"pone.0234260.ref014","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"27","author":"G. Torre-Amione","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"pone.0234260.ref015","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","article-title":"Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study","volume":"107","author":"R.S. Vasan","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"pone.0234260.ref016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"L. van Heerebeek","year":"2008","journal-title":"Circulation"},{"issue":"27","key":"pone.0234260.ref017","doi-asserted-by":"crossref","first-page":"17181727a","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"P.M. Seferovic","year":"2015","journal-title":"Eur Heart J"},{"key":"pone.0234260.ref018","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13098-018-0320-y","article-title":"Impact of diabetes mellitus on ischemic cardiomyopathy. Five-year follow-up. REVISION-DM trial","volume":"10","author":"T. Hueb","year":"2018","journal-title":"Diabetol Metab Syndr"},{"issue":"9","key":"pone.0234260.ref019","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cardfail.2007.06.723","article-title":"Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure","volume":"13","author":"J.K. Ghali","year":"2007","journal-title":"J Card Fail"},{"issue":"3","key":"pone.0234260.ref020","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejheart.2008.01.006","article-title":"Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy","volume":"10","author":"C. Fantoni","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"pone.0234260.ref021","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0002-8703(03)00403-4","article-title":"Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials","volume":"146","author":"S.J. Haas","year":"2003","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"pone.0234260.ref022","first-page":"S126","article-title":"Treatment of diabetes in people with heart failure","volume":"37","author":"Canadian Diabetes Association Clinical Practice Guidelines Expert, C","year":"2013","journal-title":"Can J Diabetes"},{"issue":"12","key":"pone.0234260.ref023","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s00392-014-0743-x","article-title":"Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry","volume":"103","author":"W. von Scheidt","year":"2014","journal-title":"Clin Res Cardiol"},{"issue":"11","key":"pone.0234260.ref024","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"M.R. MacDonald","year":"2008","journal-title":"Eur Heart J"},{"issue":"3","key":"pone.0234260.ref025","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/diacare.28.3.612","article-title":"The association between glucose abnormalities and heart failure in the population-based Reykjavik study","volume":"28","author":"I.S. Thrainsdottir","year":"2005","journal-title":"Diabetes Care"},{"issue":"9280","key":"pone.0234260.ref026","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(01)05620-3","article-title":"Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study","volume":"358","author":"M. Davies","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"pone.0234260.ref027","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ejhf.1170","article-title":"Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"P.M. Seferovic","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"pone.0234260.ref028","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"J.J. McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"9744","key":"pone.0234260.ref029","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"K. Swedberg","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"pone.0234260.ref030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cardfail.2015.12.007","article-title":"Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial","volume":"22","author":"A.Z. Banks","year":"2016","journal-title":"J Card Fail"},{"issue":"1","key":"pone.0234260.ref031","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002560","article-title":"Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial","volume":"9","author":"S.L. Kristensen","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"16","key":"pone.0234260.ref032","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/euhj.1999.2043","article-title":"Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure","volume":"21","author":"N. Suskin","year":"2000","journal-title":"Eur Heart J"},{"issue":"23","key":"pone.0234260.ref033","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group","volume":"100","author":"M. Packer","year":"1999","journal-title":"Circulation"},{"issue":"23","key":"pone.0234260.ref034","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1053\/euhj.2000.2311","article-title":"Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial","volume":"21","author":"L. Ryden","year":"2000","journal-title":"Eur Heart J"},{"issue":"22","key":"pone.0234260.ref035","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"B. Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0234260.ref036","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/CIRCULATIONAHA.117.032038","article-title":"Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)","volume":"137","author":"K.W. Mahaffey","year":"2018","journal-title":"Circulation"},{"key":"pone.0234260.ref037","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","author":"J.J.V. McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0234260.ref038","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ehf2.12336","article-title":"Empagliflozin reduces Ca\/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes","volume":"5","author":"J. Mustroph","year":"2018","journal-title":"ESC Heart Fail"},{"issue":"12","key":"pone.0234260.ref039","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/ejhf.1328","article-title":"Empagliflozin directly improves diastolic function in human heart failure","volume":"20","author":"S. Pabel","year":"2018","journal-title":"Eur J Heart Fail"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0234260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T17:27:58Z","timestamp":1591896478000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0234260"}},"subtitle":[],"editor":[{"given":"Corstiaan","family":"den Uil","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0234260","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]}}}